Skip to main content
. Author manuscript; available in PMC: 2020 Jan 15.
Published in final edited form as: ACS Biomater Sci Eng. 2019;5(11):6089–6098. doi: 10.1021/acsbiomaterials.9b00480

Table 1.

Composition of the hydrogel scaffolds used in this paper.

PEG 6 41.7μL PEG-norbornene (300mg/mL),
22.5μL Cross linker peptide (133.5mM Thiol),
98.1μL CycRGDS (15.3mM),
46.0μL 1% Irgacure 2959,
41.7μL PBS
Total Solution Volume: 250μL
PEG 8 41.7μL PEG-norbornene (300mg/mL),
22.5μL Cross linker peptide (133.5mM Thiol),
130.8μL CycRGDS (15.3mM),
46.0μL 1% Irgacure 2959,
9.0μL PBS
Total Solution Volume: 250μL
Col I 143.9μL Rat Tail Collagen I (8.34mg/mL),
7.2μL 10x PBS,
8.5μL NaOH (0.5M),
140.4μL PBS
Total Solution Volume: 300μL
Col I + Mat 143.9μL Rat Tail Collagen I (8.34mg/mL),
7.2μL 10x PBS,
8.5μL NaOH (0.5M),
72.2μL PBS,
68.2μL Matrigel (8.8mg/mL)
Total Solution Volume: 300μL
Matrigel Undiluted growth factor reduced Matrigel
(3 different lots)
HHS Vulnerability Disclosure